Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial). (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjresp-2020-000846
PubMed Identifier: 34266853
Publication URI: http://europepmc.org/abstract/MED/34266853
Type: Journal Article/Review
Volume: 8
Parent Publication: BMJ open respiratory research
Issue: 1
ISSN: 2052-4439